(929) 448-9599
FOR IMMEDIATE RELEASE
Neo Quantum Era Unveils ZPE-77: A Breakthrough in
Gout Treatment
March 19, 2025 Orlando Florida Neo Quantum Era, a leader in next generation biomedical innovation, has announced the development of ZPE-77, a cutting edge therapeutic designed to redefine the treatment of gout and metabolic disorders.
Gout affects millions worldwide, yet existing treatments rely on daily medication or repetitive IV infusions that only provide temporary relief. ZPE-77 introduces a revolutionary molecular approach that aims to regulate uric acid levels at their core, reduce inflammation, and promote long-term joint health.
“We believe ZPE-77 represents a paradigm shift in gout treatment,” said Mark Houston Brown, Chief Scientist at Neo Quantum Era. “Rather than just managing symptoms, we are developing a therapy designed to help the body regulate uric acid metabolism more effectively and sustainably.”
A New Approach to Gout Therapy
Unlike conventional treatments that focus on blocking uric acid production or breaking down existing urate crystals, ZPE-77 leverages advanced biotechnology to target the metabolic processes responsible for gout at a molecular level.
Designed as a single or limited-dose therapy, rather than lifelong medication
Utilizes next-generation bioengineering for targeted therapeutic action
Incorporates proprietary delivery technology to enhance precision and minimize side effects
Preclinical Development and Future Prospects
Neo Quantum Era is currently conducting preclinical research to validate ZPE-77’s effectiveness in regulating uric acid levels and mitigating inflammatory damage. The company is preparing for its first Investigational New Drug (IND) submission as part of its regulatory strategy for clinical trials. Neo Quantum Era is actively seeking strategic partnerships and investment to accelerate the development of ZPE-77.
About Neo Quantum Era
Neo Quantum Era is an advanced biotech company focused on revolutionizing medicine through AI-driven biointegration and next-generation therapeutics. The company’s research spans metabolic regulation, neuroregeneration, and molecular therapeutics, with an emphasis on precision medicine and long-term disease modification.
For media inquiries, investment opportunities, or collaboration discussions, please contact:
Mark Houston Brown
Chief Scientist, Neo Quantum Era
TESTIMONIALS
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Phasellus nec erat vel turpis pharetra iaculis vitae eu eros. In fermentum in risus vel tincidunt. Duis pretium, sem ut pulvinar tincidunt.
Betty Wade
Regular Patient
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Phasellus nec erat vel turpis pharetra iaculis vitae eu eros. In fermentum in risus vel tincidunt. Duis pretium, sem ut pulvinar tincidunt.
Betty Wade
Regular Patient
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Phasellus nec erat vel turpis pharetra iaculis vitae eu eros. In fermentum in risus vel tincidunt. Duis pretium, sem ut pulvinar tincidunt.
Betty Wade
Regular Patient
CONTACT US
(929) 448-9599
1317 Edgewater Dr 1874 Orlando fl 32804, New York New York 13903
© 2025 All Rights Reserved. Terms of Use and Privacy Policy